Mayne Pharma Announces Performance Rights Cessation
Company Announcements

Mayne Pharma Announces Performance Rights Cessation

Mayne Pharma Group (AU:MYX) has released an update.

Mayne Pharma Group Limited announced the cessation of 13,212 of its performance rights securities due to the non-fulfillment of conditional rights. This announcement, dated Friday, September 13, 2024, specifies that these rights lapsed because the conditions tied to them were either not satisfied or became incapable of being satisfied by September 11, 2024.

For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskMayne Pharma Hosts Investor Webinar on US Business Segments
TipRanks Australian Auto-Generated NewsdeskMayne Pharma to Highlight Growth in US Health Sectors
TipRanks Australian Auto-Generated NewsdeskInsignia Financial Acquires Stake in Mayne Pharma
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App